Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial
Author:
R.X. Zhang,X.J. Wu,D.S. Wan,Z.H. Lu,L.H. Kong,Z.Z. Pan,G. Chen
Publication:
Annals of Oncology
Copyright © 2012 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.